Wallin, M.; Ekström, M.; Garoff, H. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 2004, 23, 54-65. [CrossRef] [PubMed]
Wallin, M.; Ekström, M.; Garoff, H. Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation. J. Virol. 2006, 80, 9921-9925. [CrossRef] [PubMed]
Wyatt, R.T.; Sodroski, J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 1998, 280, 1884-1888. [CrossRef] [PubMed]
Li, K.; Zhang, S.; Kronqvist, M.; Ekstrom, M.; Wallin, M.; Garoff, H. The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase. Virology 2007, 361, 149-160. [CrossRef] [PubMed]
Gutiérrez, G.; Rodríguez, S.M.; De Brogniez, A.; Gillet, N.; Golime, R.; Burny, A.; Jaworski, J.P.; Alvarez, I.; Vagnoni, L.; Trono, K.; et al. Vaccination against -retroviruses: The bovine leukemia virus paradigm. Viruses 2014, 6, 2416-2417. [CrossRef] [PubMed]
Rodriguez, S.M.; Florins, A.; Gillet, N.; de Brogniez, A.; Sanchez-Alcaraz, M.T.; Boxus, M.; Boulanger, F.; Gutierrez, G.; Trono, K.; Alvarez, I.; et al. Preventive and therapeutic strategies for bovine leukemia virus: Lessons for HTLV. Viruses 2011, 3, 1210-1248. [CrossRef] [PubMed]
Barez, P.Y.; de Brogniez, A.; Carpentier, A.; Gazon, H.; Gillet, N.; Gutiérrez, G.; Hamaidia, M.; Jacques, J.R.; Perike, S.; Neelature Sriramareddy, S.; et al. Recent Advances in BLV Research. Viruses 2015, 7, 6080-6088. [CrossRef] [PubMed]
Florins, A.; Gillet, N.; Boxus, M.; Kerkhofs, P.; Kettmann, R.; Willems, L. Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep. J. Virol. 2007, 81, 10195-10200. [CrossRef] [PubMed]
Willems, L.; Kettmann, R.; Dequiedt, F.; Portetelle, D.; Vonèche, V.; Cornil, I.; Kerkhofs, P.; Burny, A.; Mammerickx, M. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 1993, 67, 4078-4085. [PubMed]
Florins, A.; Gillet, N.; Asquith, B.; Boxus, M.; Burteau, C.; Twizere, J.C.; Urbain, P.; Vandermeers, F.; Debacq, C.; Sanchez-Alcaraz, M.T.; et al. Cell dynamics and immune response to BLV infection: A unifying model. Front. Biosci. 2007, 12, 1520-1531. [CrossRef] [PubMed]
Willems, L.; Grimonpont, C.; Heremans, H.; Rebeyrotte, N.; Chen, G.; Portetelle, D.; Burny, A.; Kettmann, R. Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential. Proc. Natl. Acad. Sci. USA 1992, 89, 3957-3961. [CrossRef] [PubMed]
Twizere, J.C.; Kruys, V.; Lefebvre, L.; Vanderplasschen, A.; Collete, D.; Debacq, C.; Lai, W.S.; Jauniaux, J.C.; Bernstein, L.R.; Semmes, O. J.; et al. Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J. Natl. Cancer Inst. 2003, 95, 1846-1859. [CrossRef] [PubMed]
Willems, L.; Kettmann, R.; Chen, G.; Portetelle, D.; Burny, A.; Derse, D. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J. Virol. 1992, 66, 766-772. [PubMed]
Kettmann, R.; Burny, A. Bovine Leukemia Virus. In The Retroviridae; Levy, J.A. Ed.; Plenum Press: New York, NY, USA, 1994; Volume 3, pp. 39-81.
Gatot, J.S.; Callebaut, I.; Van Lint, C.; Demonté, D.; Kerkhofs, P.; Portetelle, D.; Burny, A.; Willems, L.; Kettmann, R. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J. Virol. 2002, 76, 7956-7967. [CrossRef] [PubMed]
Zarkik, S.; Defrise-Quertain, F.; Portetelle, D.; Burny, A.; Ruysschaert, J.M. Fusion of bovine leukemia virus with target cells monitored by R18 fluorescence and PCR assays. J. Virol. 1997, 71, 738-740. [PubMed]
Bruck, C.; Mathot, S.; Portetelle, D.; Berte, C.; Franssen, J.D.; Herion, P.; Burny, A. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 1982, 122, 342-352. [CrossRef]
Bai, L.; Takeshima, S.; Isogai, E.; Kohara, J.; Aida, Y. Novel CD8+ cytotoxic T cell epitopes in bovine leukemia virus with cattle. Vaccine 2015, 33, 7194-7202. [CrossRef] [PubMed]
Mamoun, R.Z.; Morisson, M.; Rebeyrotte, N.; Busetta, B.; Couez, D.; Kettmann, R.; Hospital, M.; Guillemain, B. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J. Virol. 1990, 64, 4180-4188. [PubMed]
Pikora, C.A. Glycosylation of the ENV spike of primate immunodeficiency viruses and antibody neutralization. Curr. HIV Res. 2004, 2, 243-254. [CrossRef] [PubMed]
Aguilar, H.C.; Matreyek, K.A.; Filone, C.M.; Hashimi, S.T.; Levroney, E.L.; Negrete, O.A.; Bertolotti-Ciarlet, A.; Choi, D.Y.; McHardy, I.; Fulcher, J.A.; et al. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 2006, 80, 4878-4889. [CrossRef] [PubMed]
Von V M.; Cattaneo, R. N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J. Virol. 2003, 77, 10202-10212.
Wei, X.; Decker, J. M.; Wang, S.; Hui, H.; Kappes, J. C.; Wu, X.; Salazar-Gonzalez, J.F.; Salazar, M.G.; Kilby, J.M.; Saag, M.S.; et al. Antibody neutralization and escape by HIV-1. Nature 2003, 422, 307-312. [CrossRef] [PubMed]
De Brogniez, A.; Bouzar, A.B.; Jacques, J.R.; Cosse, J.P.; Gillet, N.; Callebaut, I.; Reichert, M.; Willems, L. Mutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus. J. Virol. 2015, 89, 8945-8956. [CrossRef] [PubMed]
Vonèche, V.; Portetelle, D.; Kettmann, R.; Willems, L.; Limbach, K.; Paoletti, E.; Ruysschaert, J.M.; Burny, A.; Brasseur, R. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc. Natl. Acad. Sci. USA 1992, 89, 3810-3814. [CrossRef] [PubMed]
Gatot, J.S.; Callebaut, I.; Mornon, J.P.; Portetelle, D.; Burny, A.; Kerkhofs, P.; Kettmann, R.; Willems, L. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo. J. Biol. Chem. 1998, 273, 12870-12880. [CrossRef] [PubMed]
Lorin, A.; Lins, L.; Stroobant, V.; Brasseur, R.; Charloteaux, B. Determination of the minimal fusion peptide of bovine leukemia virus gp30. Biochem. Biophys. Res. Commun. 2007, 355, 649-653. [CrossRef] [PubMed]
Beaufils, P.; Choquet, D.; Mamoun, R.Z.; Malissen, B. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J. 1993, 12, 5105-5112. [PubMed]
Willems, L.; Gatot, J.S.; Mammerickx, M.; Portetelle, D.; Burny, A.; Kerkhofs, P.; Kettmann, R. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J. Virol. 1995, 69, 4137-4141. [PubMed]
Inabe, K.; Nishizawa, M.; Tajima, S.; Ikuta, K.; Aida, Y. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions. J. Virol. 1999, 73, 1293-1301. [PubMed]
Sagata, N.; Yasunaga, T.; Tsuzuku-Kawamura, J.; Ohishi, K.; Ogawa, Y.; Ikawa, Y. Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. USA 1985, 82, 677-681. [CrossRef] [PubMed]
Willems, L.; Thienpont, E.; Kerkhofs, P.; Burny, A.; Mammerickx, M.; Kettmann, R. Bovine leukemia virus, an animal model for the study of intrastrain variability. J. Virol. 1993, 67, 1086-1089. [PubMed]
